17 alpha-hydroxyprogesterone caproate has been researched along with 17-alpha-hydroxyprogesterone in 47 studies
Studies (17 alpha-hydroxyprogesterone caproate) | Trials (17 alpha-hydroxyprogesterone caproate) | Recent Studies (post-2010) (17 alpha-hydroxyprogesterone caproate) | Studies (17-alpha-hydroxyprogesterone) | Trials (17-alpha-hydroxyprogesterone) | Recent Studies (post-2010) (17-alpha-hydroxyprogesterone) |
---|---|---|---|---|---|
517 | 88 | 251 | 2,148 | 145 | 434 |
Protein | Taxonomy | 17 alpha-hydroxyprogesterone caproate (IC50) | 17-alpha-hydroxyprogesterone (IC50) |
---|---|---|---|
Glucocorticoid receptor | Homo sapiens (human) | 0.051 | |
Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.051 | |
Adenosine receptor A3 | Homo sapiens (human) | 4.73 | |
Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 6.3 | |
Androgen receptor | Rattus norvegicus (Norway rat) | 0.739 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 4.73 | |
Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 0.051 | |
Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.051 | |
Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.051 | |
Mitogen-activated protein kinase 3 | Homo sapiens (human) | 3.157 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 4.73 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 6.905 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 27 (57.45) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (2.13) | 29.6817 |
2010's | 4 (8.51) | 24.3611 |
2020's | 15 (31.91) | 2.80 |
Authors | Studies |
---|---|
Kollman, PA; Lee, DL; Marsh, FJ; Wolff, ME | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Doesburg, WH; Eskes, TK; Reijnders, FJ; Rolland, R; Thomas, CM | 1 |
BOSCHANN, HW | 1 |
DAVIS, ME; WIED, GL | 2 |
BORMAN, A; KESSLER, WB | 2 |
TYLER, ET | 1 |
KOFLER, E; RAUSCHER, H | 1 |
VELARDO, JT | 1 |
SMITHBERG, M | 1 |
GASSNER, FX; REIFENSTEIN, EC | 1 |
JOHNSON, KR | 1 |
COHEN, MR; GOLD, JJ | 1 |
CLARK, SL; GREENBLATT, RB | 1 |
REIFENSTEIN, EC | 1 |
EICHNER, E | 1 |
GILLESPIE, L; SEXTON, LI; WHITE, P | 1 |
BAKER, KC | 1 |
ROSSI, PG | 1 |
HASKINS, AL | 1 |
LUPU, CI; PLOTZ, EJ; WIENER, M | 1 |
HENRIKSEN, E; VARGA, A | 1 |
BROWN, WH; CIOFFI, LA; MEYERHOFF, KH | 1 |
GARRETT, WJ; SHEARMAN, RP | 1 |
DECECCO, C; LOJODICE, G; VENTO, R | 1 |
HRDY, O | 1 |
Bennett, W; Cockrell, K; Granger, JP; Keiser, SD; LaMarca, B; Martin, JN; Parrish, MR; Ray, LF; Veillon, EW | 1 |
Caritis, SN; Carpenter, M; Harper, M; Iams, JD; Lo, J; Malone, FD; Mercer, BM; Peaceman, AM; Ramin, SM; Rouse, DJ; Sciscione, A; Simhan, HN; Sorokin, Y; Spong, CY; Thorp, JM; Varner, MW; Zhao, Y | 1 |
Caritis, SN; Hauspurg, A; Venkataraman, R | 1 |
Leveno, KJ; McIntire, DD; Nelson, DB | 1 |
Caritis, SN; Combs, CA; Lemon, L; Megli, C; Venkataramanan, R | 1 |
Babbar, S; Edwards, AM; Forinash, AB; Lowry, SA; Mikovich, S | 1 |
Hesson, AM; Langen, ES; Pitts, DS | 1 |
Abdalla, A; Dotters-Katz, SK; Hynes, JS; Manuck, TA; Schwartz, AR | 1 |
Finneran, MM; Frey, HA; Hade, EM; Iams, JD; Landon, MB; Lynch, CD; Waickman, C | 1 |
Backley, S; Berghella, V; Boelig, RC; Frey, H; Gimovsky, AC; Schoen, CN; Springel, E | 1 |
Fitzsimmons, J; Mulla, W | 1 |
Biron-Shental, T; Cohen, G; Miller, N; Moran, R; Ovadia, M; Schreiber, H; Shavit, M; Shechter-Maor, G; Weitzner, O; Yagur, Y | 1 |
Beam, AL; Hakim, JB; Hart, JM; Wylie, BJ | 1 |
Smith, MM; Swamy, GK; Truong, T; Weber, JM; Wheeler, SM | 1 |
Cole, SR; Conner, MG; Freeman, BL; Kasaro, MP; Mabula-Bwalya, CM; Price, JT; Sebastião, YV; Stringer, EM; Stringer, JSA; Vwalika, B | 1 |
Badawy, ER; Mostafa, SA; Othman, MA; Shaltout, AS; Sobh, AMA | 1 |
Alshabi, A; Bastian, JR; Caritis, S; Chaphekar, N; Shaik, IH; Vasudevan, V; Venkataramanan, R; Zhao, W | 1 |
Caritis, SN; Chauhan, SP; Clark, S; Costantine, MM; Kiley, JW; Metz, TD; Stika, CS; Venkataramanan, R | 1 |
Affan, M; Ilyas, E | 1 |
1 review(s) available for 17 alpha-hydroxyprogesterone caproate and 17-alpha-hydroxyprogesterone
Article | Year |
---|---|
Racial and ethnic representation in 17-hydroxyprogesterone caproate preterm birth prevention studies: a systematic review.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Caproates; Ethnicity; Female; Humans; Infant, Newborn; Premature Birth | 2022 |
7 trial(s) available for 17 alpha-hydroxyprogesterone caproate and 17-alpha-hydroxyprogesterone
Article | Year |
---|---|
Endocrine effects of 17 alpha-hydroxyprogesterone caproate during early pregnancy: a double-blind clinical trial.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Abortion, Spontaneous; Double-Blind Method; Estrogen Antagonists; Female; Humans; Hydroxyprogesterones; Pregnancy; Pregnancy Trimester, First; Prolactin; Random Allocation; Thyroxine; Thyroxine-Binding Proteins | 1988 |
Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Adult; Biomarkers; C-Reactive Protein; Corticotropin-Releasing Hormone; Female; Gestational Age; Humans; Hydroxyprogesterones; Pregnancy; Pregnancy, Twin; Premature Birth; Progesterone; Progestins; Treatment Outcome | 2012 |
Adherence rates and outcomes for 17-hydroxyprogesterone caproate use in women with a previous history of preterm birth.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Adult; Female; Humans; Hydroxyprogesterones; Infant; Infant, Newborn; Pregnancy; Premature Birth; Retrospective Studies; United States | 2020 |
Vaginal progesterone vs intramuscular 17-hydroxyprogesterone caproate for prevention of recurrent preterm birth: a randomized controlled trial.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Female; Humans; Hydroxyprogesterones; Infant, Newborn; Pregnancy; Premature Birth; Progesterone; Progestins | 2022 |
Effect of weekly 17-hydroxyprogesterone caproate on small for gestational age among pregnant women with HIV in Zambia.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Female; Gestational Age; HIV Infections; Humans; Hydroxyprogesterones; Infant; Pregnancy; Pregnant Women; Premature Birth; Zambia | 2022 |
Effect of 17-Hydroxyprogesterone Caproate on Interleukin-6 and Tumor necrosis factor-alpha in expectantly managed early-onset preeclampsia.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Female; Humans; Infant, Newborn; Interleukin-6; Pre-Eclampsia; Pregnancy; Tumor Necrosis Factor-alpha | 2023 |
Relationship between plasma concentration of 17-hydroxyprogesterone caproate and gestational age at preterm delivery.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Female; Gestational Age; Humans; Hydroxyprogesterones; Infant, Newborn; Premature Birth | 2023 |
39 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and 17-alpha-hydroxyprogesterone
Article | Year |
---|---|
Quantitative relationships between steroid structure and binding to putative progesterone receptors.
Topics: Androstenes; Animals; Guinea Pigs; Humans; Hydroxyprogesterones; Protein Binding; Rabbits; Receptors, Progesterone; Sheep; Steroids; Structure-Activity Relationship | 1977 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
[Effect of 17-alpha-hydroxyprogesterone caproate on human endometrium].
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Caproates; Endometrium; Female; Humans; Hydroxyprogesterones; Progesterone; Steroids | 1954 |
17-Alpha-hydroxyprogesterone-caproate: a new substance with prolonged progestational activity; a comparison with chemically pure progesterone.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Caproates; Endometrium; Female; Humans; Hydroxyprogesterones; Progesterone; Steroids; Vaginal Smears | 1955 |
Comparisor of duration of action of progesterone and 17-alpha-hydroxyprogesterone-17-n-caproate.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Animals; Caproates; Estrous Cycle; Estrus; Female; Humans; Hydroxyprogesterones; Progesterone | 1957 |
The use of a new long-acting progestational compound (17-alpha-hydroxyprogesterone-capronate) in infertility and habitual abortion.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Abortion, Habitual; Abortion, Induced; Female; Humans; Hydroxyprogesterones; Infertility; Infertility, Female; Pregnancy; Progesterone; Progestins | 1956 |
Long-acting progestational agents; 17-ethinyl-19-nortestosterone enanthate, 17 alpha-hydroxyprogesterone caproate and 17-alpha-hydroxy-progesterone acetate.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Acetates; Heptanoates; Hydroxyprogesterones; Immunotherapy, Adoptive; Nandrolone; Progesterone; Progestins; Testosterone | 1957 |
[Interval of action and time of onset and duration of bleeding after the administration of the depot gestagen, 17-alpha-hydroxyprogesterone caproate].
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Caproates; Female; Hemorrhage; Humans; Hydroxyprogesterones; Menstruation Disturbances; Progesterone; Progestins | 1958 |
Some biological activities of certain progestogens. I. 17 alpha-Hydroxyprogesterone 17-n-caproate.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Caproates; Hydroxyprogesterones; Progesterone; Progestins | 1958 |
Biological action of 17 alpha-hydroxyprogesterone 17-n-caproate on the reproductive processes of the rat.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Animals; Caproates; Hydroxyprogesterones; Physiological Phenomena; Progesterone; Rats; Reproduction | 1958 |
Attempts to induce and maintain pregnancy in prepuberal mice following treatment with 17 alpha-hydroxyprogesterone 17-n-caproate.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Animals; Caproates; Hydroxyprogesterones; Mice; Pregnancy; Progesterone; Reproduction | 1958 |
Effect of 17 alpha-hydroxyprogesterone 17-n-caproate on growth and fattening of cattle.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Animals; Caproates; Cattle; Hydroxyprogesterones; Physiological Phenomena; Progesterone | 1958 |
Effect of 17 alpha-hydroxyprogesterone 17-n-caproate on the reproductive performance of cattle.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Animals; Caproates; Cattle; Hydroxyprogesterones; Progesterone; Reproduction | 1958 |
Clinical application of 17 alpha-hydroxyprogesterone 17-n-caproate.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Caproates; Estrogens; Female; Genital Diseases, Female; Humans; Hydroxyprogesterones; Progesterone | 1958 |
Effect of 17 alpha-hydroxyprogesterone 17-n-caproate on adrenal steroid excretion.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Adrenal Cortex Hormones; Caproates; Hydroxyprogesterones; Progesterone; Steroids | 1958 |
Clinical use of 17 alpha-hydroxyprogesterone 17-n-caproate in habitual abortion.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Abortion, Habitual; Abortion, Induced; Caproates; Female; Humans; Hydroxyprogesterones; Pregnancy; Progesterone | 1958 |
Clinical use of 17 alpha-hydroxyprogesterone 17-n-caproate in the prevention of premature labor, and its effect upon fetal salvage.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Caproates; Female; Fetus; Humans; Hydroxyprogesterones; Labor, Obstetric; Obstetric Labor, Premature; Pregnancy; Progesterone | 1958 |
Treatment of human diabetic pregnancies with estradiol valerate and 17 alpha-hydroxyprogesterone 17-n-caproate.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Caproates; Diabetes Mellitus; Estradiol; Female; Humans; Hydroxyprogesterones; Pregnancy; Pregnancy in Diabetics; Progesterone | 1958 |
Treatment of persistent acne in women with 17 alpha hydroxyprogesterone caproate (delalutin); a preliminary report.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Acne Vulgaris; Caproates; Hydroxyprogesterones; Progesterone | 1958 |
[Effect of progesterone, 17 alpha-hydroxyprogesterone acetate & hydroxyprogesterone caproate on the changes of uterine dynamics after deplorization of the membrane & subtraction of calcium: experimental data].
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Acetates; Calcium, Dietary; Female; Humans; Hydroxyprogesterones; Membranes; Progesterone; Uterus | 1959 |
The luteal effect of topically administered 17-alpha-hydroxyprogesterone caproate.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Caproates; Corpus Luteum; Female; Humans; Hydroxyprogesterones; Progesterone | 1959 |
Metabolism of 17 alpha-hydroxyprogesterone-4-C14-17 alpha-caproate by homogenates of rat liver and human placenta.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Caproates; Female; Humans; Hydroxyprogesterones; Liver; Placenta; Pregnancy; Progesterone | 1961 |
Clinical and histopathologic evaluation of the effect of 17-alpha-hydroxyprogesterone-17-n-caproate on endometral carcinoma.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Adenocarcinoma; Adenocarcinoma, Papillary; Caproates; Female; Humans; Hydroxyprogesterones; Progesterone; Uterine Neoplasms | 1961 |
The use of 17-alpha-hydroxyprogesterone caproate to maintain pregnancy.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Abortion, Induced; Abortion, Spontaneous; Caproates; Female; Humans; Hydroxyprogesterones; Pregnancy; Progestins | 1962 |
Double-blind study of effect of 17-hydroxyprogesterone caproate on abortion rate.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Abortion, Habitual; Abortion, Induced; Abortion, Spontaneous; Caproates; Double-Blind Method; Female; Humans; Hydroxyprogesterones; Pregnancy | 1963 |
[FEMALE PSEUDOHERMAPHRODITISM PROBABLY INDUCED BY A PROGESTINIC ADMINISTERED INTRAMUSCULARLY: 17-ALPHA-HYDROXYPROGESTERONE CAPRONATE].
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; 46, XX Disorders of Sex Development; Abnormalities, Drug-Induced; Abortion, Threatened; Disorders of Sex Development; Female; Humans; Hydroxyprogesterones; Infant; Infant, Newborn; Pregnancy; Progestins; Toxicology | 1964 |
[17-ALPHA-HYDROXYPROGESTERONE CAPROATE].
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Caproates; Chemistry, Pharmaceutical; Humans; Hydroxyprogesterones; Pharmacopoeias as Topic; Pharmacy | 1964 |
17-Hydroxyprogesterone blunts the hypertensive response associated with reductions in uterine perfusion pressure in pregnant rats.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Animals; Endothelin-1; Female; Hydroxyprogesterones; Ischemia; Placenta; Placental Circulation; Pregnancy; Progesterone Congeners; Rats; Tumor Necrosis Factor-alpha | 2009 |
Evaluation of 17-alpha hydroxyprogesterone caproate efficacy.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Hydroxyprogesterones; Progestins | 2018 |
Defining 17OHP-C responsiveness.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Female; Humans; Pregnancy; Premature Birth | 2019 |
Recurrent Preterm Birth Reduction by 17-Hydroxyprogesterone Caproate in Dichorionic/Diamniotic Twin Gestation.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Female; Humans; Infant, Newborn; Pregnancy; Pregnancy, Twin; Premature Birth; Prospective Studies; Randomized Controlled Trials as Topic | 2022 |
Delivering equity: preterm birth by socioeconomic class before and after coverage of 17-hydroxyprogesterone caproate.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Female; Humans; Hydroxyprogesterones; Infant, Newborn; Premature Birth; Retrospective Studies; Socioeconomic Factors; United States | 2022 |
17-hydroxyprogesterone caproate for women with congenital uterine anomalies: does it impact the risk of recurrent preterm birth?
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Female; Humans; Infant, Newborn; Pregnancy; Premature Birth; Urogenital Abnormalities; Uterus | 2021 |
A Comparison of Vaginal and Intramuscular Progesterone for the Prevention of Recurrent Preterm Birth.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Female; Humans; Hydroxyprogesterones; Infant, Newborn; Pregnancy; Premature Birth; Progesterone; Retrospective Studies | 2023 |
The 17-alpha hydroxyprogesterone chronicle.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Humans; Hydroxyprogesterones | 2022 |
Can 17 hydroxyprogesterone caproate (17P) decrease preterm deliveries in patients with a history of PMC or pPROM?
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Obstetric Labor, Premature; Pregnancy; Premature Birth; Retrospective Studies | 2022 |
Regional differences in utilization of 17α-hydroxyprogesterone caproate (17-OHP).
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Cohort Studies; Female; Humans; Hydroxyprogesterones; Infant, Newborn; Pregnancy; Premature Birth; Retrospective Studies | 2022 |
Effect of formulation and route of administration on the distribution of 17-hydroxyprogesterone caproate in rats.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Animals; Female; Humans; Hydroxyprogesterones; Infant, Newborn; Premature Birth; Rats; Rats, Sprague-Dawley | 2023 |
Discontinuation Of Long-Established Hydroxyprogesterone Caproate; Call For Awareness And Drug-Substitutes: A Letter To The Editor.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Female; Humans; Premature Birth | 2023 |